A Study to Learn About How the Flu and COVID-19 Vaccines Act in Healthy People
Purpose
The purpose of this study is to learn about how the flu and COVID vaccines act when given alone or when mixed together. This study is seeking healthy participants aged 18 or older. All participants in this study will receive only 1 shot to their arm, either a flu or COVID vaccine, alone or mixed. Participants will take part in this study for about 6 months, and participants will need to visit the clinical study site at least 4 times.
Conditions
- Influenza
- COVID-19 (Coronavirus Disease 2019)
Eligibility
- Eligible Ages
- Over 18 Years
- Eligible Sex
- All
- Accepts Healthy Volunteers
- Yes
Inclusion Criteria
- Participants 18 years of age or older - Healthy participants who are determined by medical history, physical examination (if clinically required), and clinical judgement of the investigator to be eligible for inclusion in the study
Exclusion Criteria
- Vaccination with any investigational or licensed influenza vaccine within 150 days of enrollment - Vaccination with any investigational or licensed COVID 19 vaccine within 150 days of enrollment. - Receipt of antiviral therapies for influenza (eg, Tamiflu) within 180 days prior to Day 1. Refer to the study contact for further eligibility details
Study Design
- Phase
- Phase 1/Phase 2
- Study Type
- Interventional
- Allocation
- Randomized
- Intervention Model
- Parallel Assignment
- Primary Purpose
- Prevention
- Masking
- Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Arm Groups
Arm | Description | Assigned Intervention |
---|---|---|
Experimental Arm A |
Low Dose COVID-19 Vaccine (1a) |
|
Experimental Arm B |
Low Dose COVID-19 Vaccine ( 1b) |
|
Experimental Arm C |
Low Dose COVID-19 Vaccine ( 1c) |
|
Experimental Arm D |
Investigational Influenza and COVID-19 Combination Vaccine (High Dose Combination 1) |
|
Experimental Arm E |
Investigational Influenza and COVID-19 Combination Vaccine (Medium Dose Combination 2) |
|
Experimental Arm F |
Investigational Influenza and COVID-19 Combination Vaccine (High Dose Combination 3) |
|
Experimental Arm G |
Investigational Influenza and COVID-19 Combination Vaccine (High Dose Combination 4) |
|
Active Comparator Arm H |
Licensed COVID-19 Vaccine |
|
Active Comparator Arm I |
Licensed Influenza Vaccine (1) |
|
Experimental Arm J |
Investigational Influenza and COVID-19 Combination Vaccine (High Dose Combination 5) |
|
Experimental Arm K |
Investigational Influenza and COVID-19 Combination Vaccine (High Dose Combination 6) |
|
Experimental Arm L |
Investigational Influenza and COVID-19 Combination Vaccine (High Dose Combination 7) |
|
Active Comparator Arm M |
Licensed COVID-19 Vaccine |
|
Active Comparator Arm N |
Licensed Influenza Vaccine (2) |
|
Experimental Arm AA |
Investigational Influenza and COVID-19 Combination Vaccine (High Dose Combination 6) |
|
Experimental Arm BB |
Investigational Influenza and COVID-19 Combination Vaccine (High Dose Combination 4) |
|
Experimental Arm CC |
Investigational Influenza and COVID-19 Combination Vaccine (High Dose Combination 7) |
|
Experimental Arm DD |
Investigational Influenza and COVID-19 Combination Vaccine (Medium Dose Combination 2) |
|
Experimental Arm EE |
Investigational Influenza and COVID-19 Combination Vaccine (High Dose Combination 3) |
|
Active Comparator Arm FF |
Licensed COVID-19 Vaccine |
|
Active Comparator Arm GG |
Licensed Influenza Vaccine (3) |
|
Active Comparator Arm HH |
Licensed Influenza Vaccine (2) |
|
Experimental Arm II |
Low Dose COVID-19 Vaccine ( 1b) |
|
Experimental Arm JJ |
Low Dose COVID-19 Vaccine ( 1c) |
|
Experimental Arm KK |
Investigational Influenza and COVID-19 Combination Vaccine (High Dose Combination 4) |
|
Experimental Arm LL |
Investigational Influenza and COVID-19 Combination Vaccine (High Dose Combination 7) |
|
Experimental Arm MM |
Investigational Influenza and COVID-19 Combination Vaccine (Medium Dose Combination 2) |
|
Experimental Arm NN |
Investigational Influenza and COVID-19 Combination Vaccine (High Dose Combination 3) |
|
Experimental Arm OO |
Investigational Influenza and COVID-19 Combination Vaccine (High Dose Combination 5) |
|
Experimental Arm PP |
Medium Dose Investigational Influenza Vaccine (1) |
|
Experimental Arm QQ |
High Dose Investigational Influenza Vaccine (2) |
|
Active Comparator Arm RR |
Licensed COVID-19 Vaccine |
|
Active Comparator Arm SS |
Licensed Influenza Vaccine (3) |
|
Recruiting Locations
Anaheim 5323810, California 5332921 92801
Lake Forest 5364514, California 5332921 92630
Riverside 5387877, California 5332921 92503
San Diego 5391811, California 5332921 92103
Walnut Creek 5406990, California 5332921 94598
Milford 4838652, Connecticut 4831725 06460
Coral Gables 4151871, Florida 4155751 33134
Hialeah 4158476, Florida 4155751 33012
Miami 4164138, Florida 4155751 33176
Miami Lakes 4164186, Florida 4155751 33014
Stockbridge 4224681, Georgia 4197000 30281
Honolulu 5856195, Hawaii 5855797 96814
Chesterfield 4381072, Missouri 4398678 63005
North Las Vegas 5509403, Nevada 5509151 89030
East Syracuse 5116079, New York 5128638 13057
Rochester 5134086, New York 5128638 14642
Wilmington 4499379, North Carolina 4482348 28403
Columbus 4509177, Ohio 5165418 43213
Philadelphia 4560349, Pennsylvania 6254927 19107
North Charleston 4589387, South Carolina 4597040 29405
Knoxville 4634946, Tennessee 4662168 37909
Knoxville 4634946, Tennessee 4662168 37920
Nashville 4644585, Tennessee 4662168 37203
Brownsville 4676740, Texas 4736286 78526
Houston 4699066, Texas 4736286 77065
Mesquite 4710826, Texas 4736286 75149
Tomball 4737094, Texas 4736286 77375
Salt Lake City 5780993, Utah 5549030 84109
Salt Lake City 5780993, Utah 5549030 84121
Charlottesville 4752031, Virginia 6254928 22911
Seattle 5809844, Washington 5815135 98101
More Details
- NCT ID
- NCT06821061
- Status
- Recruiting
- Sponsor
- BioNTech SE